Community
Company
News
Contact Us
Sign in

Please select the option that best describes you:

Topics: Rheumatology • Vasculitis

How do you approach treatment of livido vasculitis?

Does your treatment change if there are open ulcers?

Related Questions

Would you pursue a kidney biopsy in a patient with stable stage 1 AKI, bland urine sediment, and a positive MPO titer without systemic signs of vasculitis?

How do you approach tapering of tocilizumab used for a history of GCA with vision loss?

What are clues to diagnose relapsing polychondritis with airway involvement, without any chondral inflammation?

What options are available for patients who require high dose steroids while taking strong CYP4A4 inducers?

Would you consider anti-IL-5 therapy (mepolizumab or benralizumab) to either prevent or treat the more severe manifestations of eosinophilic granulomatosis with polyangiitis, such as "infiltrative" (e.g., cardiomyopathy, pulmonary infiltrates, or gastroenteritis) or "vasculitic" (e.g., neuropathy, palpable purpura, or glomerulonephritis)?

How would you approach management of a young woman referred for isolated active anterior scleritis with a history of resolved right eye iritis, in the absence of systemic manifestations or end-organ involvement, but with serologies notable for strongly positive MPO and p-ANCA antibodies?

How would you approach failure of maintenance therapy (Azathioprine) for PR3 positive, c-ANCA positive, pulmonary–renal vasculitis previously induced with cyclophosphamide, with a history of anaphylaxis to rituximab?

What biologic or conventional/synthetic DMARD would you use as a steroid sparing agent in a patient with GCA and a history of diverticulitis?

How do you approach worsening memory loss in patients with GCA?

How would you approach a patient with high CRP, rising liver enzymes and new biopsy proven liver granulomas 6 months after starting methotrexate and Rituximab therapy for ANCA vasculitis?

Copyright © 2026 theMednet
All Rights Reserved.